# Benef: __Reduction in aerosol transmission__ (PBN__Benef_752)

## Property: has_Beneficiary

* [building occupants](../Stakeholder/PBN__Stakeholder_97)
* [patients](../Stakeholder/PBN__Stakeholder_31)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)

## Property: has_BenefDetails

Air filtration devices reduce the likelihood of airborne transmission of SARS-CoV-2, protecting both patients and healthcare workers from infection.

## Property: has_BenefSource

* [spennemann_designing_2022](../Article/PBN__Article_149)
* [conway-morris_removal_2021](../Article/PBN__Article_232)

## Property: has_BenefReturn

* [Private investors benefit from reduced transmission rates, a healthier and more confident population, and potential increase in asset values.](../BenefReturn/PBN__BenefReturn_817)
* [Private investors would benefit from investing in air filtration devices as it would improve patient safety and reduce healthcare costs associated with infections.](../BenefReturn/PBN__BenefReturn_1253)

